Predictive factors in patients with EGFR mutation-negative non-small cell lung cancer treated with erlotinib

Factors predicting the efficacy of erlotinib treatment in patients with EGFR mutation-negative non-small-cell lung cancer (NSCLC) have not been well studied. This retrospective study investigates whether patient characteristics, such as site of metastasis, can predict the efficacy of erlotinib treat...

Descripción completa

Detalles Bibliográficos
Autores principales: ISHII, HIDENOBU, AZUMA, KOICHI, YAMADA, KAZUHIKO, KINOSHITA, TAKASHI, IMAMURA, YOUHEI, HOSHINO, TOMOAKI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214475/
https://www.ncbi.nlm.nih.gov/pubmed/25364452
http://dx.doi.org/10.3892/ol.2014.2548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214475/
https://www.ncbi.nlm.nih.gov/pubmed/25364452
http://dx.doi.org/10.3892/ol.2014.2548

Ejemplares similares